Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison

Tools

Item Type:	Article
Title:	Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison
Creators Name:	Kern, W., Aul, C., Maschmeyer, G., Schoenrock-Nabulsi, R., Ludwig, W.D., Bartholomaeus, A., Bettelheim, P., Woermann, B., Buechner, T. and Hiddemann, W.
Source:	Leukemia
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Volume:	12
Page Range:	1049-1055
Date:	1 July 1998
PubMed:	View item in PubMed

Repository Staff Only: item control page